Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report.

al amyloidosis b-cell lymphoma bortezomib congo red hematology-oncology marginal zone lymphoma mzl

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2022
Historique:
accepted: 02 07 2022
entrez: 4 8 2022
pubmed: 5 8 2022
medline: 5 8 2022
Statut: epublish

Résumé

Immunoglobulin light chain (AL) amyloidosis is a systemic disease in which different systems such as kidneys, heart, and lungs are affected by the deposition of amyloid, a form of fibrillary protein. Usually, it occurs in patients with pre-existing diagnoses of plasma cell dyscrasias and is rarely seen in the concurrence of marginal zone lymphoma (MZL). Earlier interventions with cyclophosphamide and dexamethasone in conjunction with newer therapies such as bortezomib, carfilzomib or lenalidomide, and pomalidomide are being used to treat patients with AL amyloidosis. In this report, we are presenting a unique case of a patient who was diagnosed with AL amyloidosis several years prior to presenting with a soft tissue mass, which was subsequently noted to be an amyloid mass within an MZL. Overall, the occurrence of AL amyloidosis and MZL is rare with less than 20 patients reported. The MZL developed prior to or simultaneously with AL amyloidosis in the reported cases. Therefore, to our knowledge, this is the first time systemic amyloidosis has preceded MZL.

Identifiants

pubmed: 35923498
doi: 10.7759/cureus.26517
pmc: PMC9339382
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e26517

Informations de copyright

Copyright © 2022, Doshi et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Dermatopathol. 2019 Jul;41(7):518-521
pubmed: 30839349
Chin J Cancer. 2010 Jun;29(6):634-40
pubmed: 20507739
Virchows Arch. 2019 Mar;474(3):353-363
pubmed: 30680453
Blood. 1985 Aug;66(2):291-3
pubmed: 2990608
Blood. 2020 Jan 23;135(4):293-296
pubmed: 31714952
J Clin Oncol. 2011 May 10;29(14):1924-33
pubmed: 21483018
Leuk Lymphoma. 2016;57(3):557-62
pubmed: 26065437
Lancet. 2016 Jun 25;387(10038):2641-2654
pubmed: 26719234
Nephrol Dial Transplant. 2019 Sep 1;34(9):1460-1466
pubmed: 30299492
Am J Surg Pathol. 2017 Aug;41(8):1069-1076
pubmed: 28505007
Am J Surg Pathol. 2013 Mar;37(3):406-12
pubmed: 23282974
Blood. 1989 Nov 1;74(6):2062-5
pubmed: 2804347

Auteurs

Krishna Doshi (K)

Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, USA.

Jacob Bitran (J)

Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, USA.

Brian Adley (B)

Pathology, Advocate Lutheran General Hospital, Park Ridge, USA.

Nahren Asado (N)

Pathology, Advocate Lutheran General Hospital, Park Ridge, USA.

Classifications MeSH